Effect of a Probiotic Water on Oral Health in Adults

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-20

Study Completion Date

2020-08-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effects of consuming a probiotic on salivary, plaque, and tongue bacteria, as well as oral malodor (bad breath). Healthy volunteers will consume a probiotic powder, or a placebo powder, that is dissolved in water for 4 weeks.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)

NCT01520974

Oral Health

UNKNOWN NA

The Effect of Probiotics on Gums Health and Bad Breath

NCT06910397

Gingivitis

COMPLETED NA

Double-blind Clinical Trials of Probiotic Products in Oral Health.

NCT04289337

Probiotics Oral Health Probiotic Metabolites

COMPLETED NA

Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis

NCT02789436

Halitosis

UNKNOWN PHASE4

The Effect of Probiotics on Gingivitis

NCT05727436

Gingivitis; Chronic

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The oral cavity houses one of the most diverse microbiota in the human body. There are nearly 800 unique oral bacterial species identified with more species expected to be added with further sampling and identification. As with microbiota of other sites in the body, a balanced oral microbiota is essential to maintaining the health of the human host. Streptococcus salivarius is a pioneer species that colonizes the human oral cavity from birth, and remains a predominant member of the commensal microbiota throughout life. The commensal microbiota provides protection against pathogenic species associated with conditions such as dental caries, periodontal disease, and oral malodor (halitosis). This randomized, double-blind, placebo-controlled study is conducted to investigate the effect of a Streptococcus salivarius DB-B5 strain on oral bacteria levels and halitosis. Doses of 2 billion and 10 billion colony forming units (CFU) per day are tested.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Bacteria Halitosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotic - low dose

Powdered probiotic with a carrier.

Group Type EXPERIMENTAL

Streptococcus salivarius DB-B5 - 2 billion CFU/day

Intervention Type DIETARY_SUPPLEMENT

The participants (n=15) will consume sachets containing Streptococcus salivarius DB-B5 (at 1 billion CFU/sachet) dissolved in water twice daily for 4 weeks.

Probiotic - high dose

Powdered probiotic with a carrier.

Group Type EXPERIMENTAL

Streptococcus salivarius DB-B5 - 10 billion CFU/day

Intervention Type DIETARY_SUPPLEMENT

The participants (n=15) will consume sachets containing Streptococcus salivarius DB-B5 (at 5 billion CFU/sachet) dissolved in water twice daily for 4 weeks.

Placebo

Carrier only.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

The participants (n=15) will consume sachets containing a placebo (probiotic carrier) twice daily for 4 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Streptococcus salivarius DB-B5 - 2 billion CFU/day

The participants (n=15) will consume sachets containing Streptococcus salivarius DB-B5 (at 1 billion CFU/sachet) dissolved in water twice daily for 4 weeks.

Intervention Type DIETARY_SUPPLEMENT

Streptococcus salivarius DB-B5 - 10 billion CFU/day

The participants (n=15) will consume sachets containing Streptococcus salivarius DB-B5 (at 5 billion CFU/sachet) dissolved in water twice daily for 4 weeks.

Intervention Type DIETARY_SUPPLEMENT

Placebo

The participants (n=15) will consume sachets containing a placebo (probiotic carrier) twice daily for 4 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults, 18 to 65 years of age and in good general health and good oral health (no active or uncontrolled diseases or conditions).
2. Presence of at least 20 natural teeth, excluding third molars.
3. Read and sign the Research Subject Information and Consent Form.
4. Have an OralChroma reading ≥ 125 ppb hydrogen sulfide (H2S) gas, volatile sulfur compound (VSC) (at least 8-12 hours after eating or drinking or oral hygiene) at Baseline.
5. Willingness to use the assigned products according to instructions, attend scheduled appointments, and likelihood of completing the study.
6. Males and females with reproductive potential agree to use medically acceptable contraception, as determined by the investigator, for the duration of the study and 30 days after study completion and attest to having used it for three months prior to screening.
7. Females of child-bearing potential agree to submit to a urine pregnancy test at screening and at the end of the study.

Exclusion Criteria

1. Fewer than 20 natural, uncrowned teeth.
2. Active or chronic dental disease.
3. Self-reported dry mouth (xerostomia) by questionnaire.
4. Have had or used any of the following in the past three months: antibiotic treatment, a dental cleaning, mouthrinse.
5. Regular use of probiotic supplements or regular consumption of probiotic rich foods such as yoghurt or kefir in the past month.
6. Require antibiotic prophylaxis for dental or any treatment.
7. Removable or fixed dental appliances (no implants; crowns allowed if subject has at least 20 uncrowned teeth)
8. Pregnant or planning to become pregnant during the study period, or breastfeeding.
9. Uses tobacco products (including smokeless, vaping, and nicotine chewing gums/sprays/lozenges).
10. Chronic or acute illness such as heart disease, diabetes, cancer, autoimmune condition or HIV that could impact outcome of the study in the opinion of the investigator.
11. Use of a dental product or is on a medication/treatment that could impact outcome of the study in the opinion of the investigator.
12. Is unwilling or unable to provide informed consent and follow study procedures.
13. Has participated in any clinical study within 30 days.
14. Clinical site personnel or relative or partner of clinical site personnel.
15. Any other condition or situation that may increase the risk associated with study participation or may interfere with the study results in the opinion of the investigator.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes